Looking for API CDMO Partner? Looking for API CDMO Partner?

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Find the latest news about The University of Texas MD Anderson Cancer Center aggregated by PharmaCompass.com.

    Client Virtual Booth

    THE UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    DOSSIERs // Finished Dosage Formulations

    PharmaCompass
    Contact SupplierContact Supplier
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Send me more info on How To Grow My Bussiness Digitally?
    The University of Texas MD Anderson Cancer Center
    United_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    1515 Holcombe Blvd. Houston, Texas 77030
    Telephone
    Telephone
    1-855-900-4299
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.mdanderson.org/
    Linkedin
    Linkedin
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Full View ScreenFull Screen View
    Ori Biotech Partners with the Cell Therapy MFG Center to Accelerate Cell Therapy
    Ori Biotech Partners with the Cell Therapy MFG Center to Accelerate Cell Therapy

    https://www.contractpharma.com/contents/view_breaking-news/2022-09-13/ori-biotech-partners-with-the-cell-therapy-manufacturing-center-to-accelerate-cell-therapy-delivery/?widget=listSection

    CONTRACTPHARMA
    13 Sep 2022
    Share Share
    Virogin Biotech and MD Anderson Announce Strategic Collaboration
    Virogin Biotech and MD Anderson Announce Strategic Collaboration

    https://www.globenewswire.com/news-release/2022/09/08/2512915/0/en/Virogin-Biotech-and-MD-Anderson-Announce-Strategic-Collaboration-to-Accelerate-Oncolytic-Virus-Research-and-Development-for-Treating-Advanced-Cancers.html

    GLOBENEWSWIRE
    08 Sep 2022
    Share Share
    Erasca and MD Anderson Announce Strategic Research and Development Collaboration in RAS/MAPK-Driven Cancers
    Erasca and MD Anderson Announce Strategic Research and Development Collaboration in RAS/MAPK-Driven Cancers

    https://investors.erasca.com/news-releases/news-release-details/erasca-and-md-anderson-announce-strategic-research-and

    PRESS RELEASE
    23 Aug 2022
    Share Share
    No Q2 call yet for Vivos; San Diego biotech collabs with MD Anderson
    No Q2 call yet for Vivos; San Diego biotech collabs with MD Anderson

    https://endpts.com/no-q2-call-for-a-colorado-medtech-san-diego-biotech-collabs-with-md-anderson/

    Kyle LaHucik ENDPTS
    23 Aug 2022
    Share Share
    Turning Point, MD Anderson Enter Alliance to Advance Precision Cancer Therapies
    Turning Point, MD Anderson Enter Alliance to Advance Precision Cancer Therapies

    https://www.globenewswire.com/news-release/2022/06/24/2468792/0/en/Turning-Point-Therapeutics-and-MD-Anderson-Announce-Strategic-Alliance-to-Advance-Precision-Cancer-Therapies.html

    GLOBENEWSWIRE
    24 Jun 2022
    Share Share
    Invectys, MD Anderson And CTMC Announce Collaboration For Car T Cell Therapy
    Invectys, MD Anderson And CTMC Announce Collaboration For Car T Cell Therapy

    https://www.globenewswire.com/news-release/2022/06/16/2464034/0/en/INVECTYS-MD-ANDERSON-AND-CTMC-ANNOUNCE-STRATEGIC-COLLABORATION-FOR-CAR-T-CELL-THERAPY-DEVELOPMENT.html

    GLOBENEWSWIRE
    16 Jun 2022
    Share Share
    Resilience forges JV with MD Anderson, readying new cell therapies for cancer
    Resilience forges JV with MD Anderson, readying new cell therapies for cancer

    https://endpts.com/resilience-forges-jv-with-md-anderson-readying-new-cell-therapies-for-cancer/

    Tyler Patchen ENDPTS
    06 Jun 2022
    Share Share
    Alpha Tau signs research pact with MD Anderson to study potential of Alpha DaRT
    Alpha Tau signs research pact with MD Anderson to study potential of Alpha DaRT

    http://www.pharmabiz.com/NewsDetails.aspx?aid=145349&sid=2

    PHARMABIZ
    21 Jan 2022
    Share Share
    Yingli Pharma, MD Anderson Collaborate for Multiple Oncology Programs
    Yingli Pharma, MD Anderson Collaborate for Multiple Oncology Programs

    https://www.globenewswire.com/news-release/2022/01/20/2370411/0/en/Yingli-Pharma-and-MD-Anderson-Initiate-Strategic-Collaboration-to-Advance-Development-of-Multiple-Oncology-Programs.html

    GLOBENEWSWIRE
    20 Jan 2022
    Share Share
    Avenge Bio uncloaks with $45M and a slate of immunotherapies
    Avenge Bio uncloaks with $45M and a slate of immunotherapies

    https://endpts.com/taking-notes-from-md-anderson-and-rice-university-avenge-bio-uncloaks-with-45m-and-a-slate-of-immunotherapies/

    Nicole DeFeudis ENDPTS
    05 Jan 2022
    Share Share
    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    seqens-m-2023-05-22

    Access Virtual Booth

    Contact Supplier

    Send me more info on How To Grow My Business Digitally?
    Post Enquiry
    POST ENQUIRY

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search